Gastrointestinal side effects are common during ovarian cancer treatment and can affect comfort, nutrition, and daily life. In this episode of Teal Talk – An Ovarian Cancer Podcast, nurse clinician and NOCC Board member Tiffani Mickens, RN, explains why these side effects occur and offers practical guidance for managing them. The conversation also covers warning signs, including severe dehydration or bowel obstruction, and emphasizes the importance of reaching out to your care team early.

This episode provides education, reassurance, and encouragement for survivors, caregivers, and advocates navigating treatment. Listening can help you track symptoms, ask questions, and feel empowered during recovery.

💙 Learn more about ovarian cancer and the National Ovarian Cancer Coalition: ovarian.org 📋 Share your feedback: bit.ly/tealtalksurvey

This podcast is for informational purposes only and does not replace professional medical advice.

Ovarian cancer is not one disease, and for some people, a rare subtype can make diagnosis and treatment feel confusing and isolating. In this episode of Teal Talk–An Ovarian Cancer Podcast, gynecologic oncologist Dr. Rick Bouley and an ovarian cancer survivor come together to explain rare ovarian cancer subtypes and share what it means to navigate a diagnosis that does not follow a typical path.

This episode offers education, reassurance, and hope for anyone facing ovarian cancer, especially those navigating a rare diagnosis.

💙 Learn more about ovarian cancer and the National Ovarian Cancer Coalition: ovarian.org 📋 Share your feedback: bit.ly/tealtalksurvey

This podcast is for informational purposes only and does not replace professional medical advice.

In this episode of Teal Talk – An Ovarian Cancer Podcast, Dr. Michael Birrer, a leading expert in ovarian cancer, explains how treatment has progressed from standard chemotherapy to more targeted therapies, molecular testing, and precision medicine designed around each patient’s tumor.

Listeners will learn about bevacizumab, PARP inhibitors, antibody drug conjugates (ADCs), immunotherapy, and why clinical trials are essential for bringing new treatment options forward. The conversation also covers genetic and biomarker testing, family risk, and how to start informed and confident discussions with a care team.

💙 Learn more about ovarian cancer and the National Ovarian Cancer Coalition: ovarian.org 📋 Share your feedback: bit.ly/tealtalksurvey

This podcast is for informational purposes only and does not replace professional medical advice.